Author Correction: Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation

Publication date

2026-04-13

Authors

Kimman, Thomas
Cuenca, Marta
Tieland, Ralph G.
Rockx-Brouwer, Dedeke
Janssen, Jasmijn
Motais, Benjamin
Slomp, Anne
Pleijte, Corine
Heijhuurs, Sabine
Meringa, Angelo

Editors

Advisors

Supervisors

Document Type

Comment

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

Keywords

Citation

Kimman, T, Cuenca, M, Tieland, R G, Rockx-Brouwer, D, Janssen, J, Motais, B, Slomp, A, Pleijte, C, Heijhuurs, S, Meringa, A D, Boschloo, W, Bosma, D M T, Kroos, S, Lo Presti, V, Sluijter, J P G, Nierkens, S, Bovenschen, N, Kuball, J, van Mil, A, Minnema, M C, Sebestyén, Z & Peperzak, V 2026, 'Author Correction : Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation', Nature Communications, vol. 17, no. 1, 3442. https://doi.org/10.1038/s41467-026-71859-1